You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Johnson and Johnson
Moodys
Express Scripts
Baxter

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

SOLAGE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Solage, and what generic alternatives are available?

Solage is a drug marketed by Almirall and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in twelve countries.

The generic ingredient in SOLAGE is mequinol; tretinoin. Additional details are available on the mequinol; tretinoin profile page.

US ANDA Litigation and Generic Entry Outlook for Solage

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be August 24, 2020. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

  Start Trial

Summary for SOLAGE
International Patents:13
US Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: 116
Patent Applications: 8,562
Formulation / Manufacturing:see details
DailyMed Link:SOLAGE at DailyMed
Drug patent expirations by year for SOLAGE
Generic Entry Opportunity Date for SOLAGE
Generic Entry Date for SOLAGE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for SOLAGE
.beta.-all-trans-Retinoic acid
.beta.-Retinoic acid
(11Z)-retinoic acid
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aenoic acid
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2E,4E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid
(4E,6E,8E)-9-(2,6,6-Trimethyl-1-cyclohexenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid
(5E)-Retinoic acid
(9Z,13Z)-Retinoic acid
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
[3H]RA
[3H]Retinoic acid
[3H]tretinoin
[3H]Vitamin A acid
[All-E]-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
02T794
15-Apo-beta-caroten-15-oic acid
1cbr
1n4h
2,4, 6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-, (2E, 4E, 6E, 8E)-
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)--, (all trans)-
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-
2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-
2,4,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all trans)-
2,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-
2,6,8-Nonatetranoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-
3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid-, (all trans)-
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2E,4E,6E,8E,-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL)
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-all-trans-tetraenoic acid
3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2E,4E,6E,8E-tetraenoic acid
302-79-4
33998-EP2275420A1
33998-EP2295055A2
33998-EP2295416A2
33998-EP2295426A1
33998-EP2295427A1
33998-EP2298748A2
33998-EP2298764A1
33998-EP2298765A1
33998-EP2298768A1
33998-EP2301928A1
33998-EP2305642A2
33998-EP2308833A2
33998-EP2308861A1
33998-EP2311453A1
33998-EP2311808A1
33998-EP2311829A1
33998-EP2311840A1
4759-48-2
5688UTC01R
5914-EP2275412A1
5914-EP2292576A2
6-s-trans-retinoic acid
9-cis-RA
9-cis-retinoic acid (9cRA)
97950-17-9
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
A10944
AB00052318_18
AB00052318_19
AB00052318-15
AB00052318-16
AB00052318-17
AB03039
AB1009361
Aberel
Aberela
Aberela [Norway]
AC-6824
Acid A Vit (Belgium, Netherlands)
acide retinoique (French)
Acide retinoique (French) (DSL)
Acnavit
Acnavit [Denmark]
ACT00012
AGN 100335
Airol
Aknefug
Aknoten
AKOS000280845
All Trans Retinoic Acid
all trans-Retinoic acid
all-(E)-Retinoate
all-(E)-Retinoic acid
All-trans Retinoic Acid
All-trans Retinoic Acid (Tretinoin)
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
all-trans-Retinoic acid
all-trans-retinoic acid (ATRA)
all-trans-Retinoic acid, 97%
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
Alltrans-retinoic acid
Altreno (0.05% lotion)
ARONIS25153
AT-RA
ATRA
ATRA; Tretinoin; Vitamin A acid; all-trans-Retinoic acid
Atragen
Atralin
Avita (0.025% gel)
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
b-Retinoic acid
BCP01405
BCPP000036
BDBM31883
BDBM323588
beta-Ra
beta-Retinoate
beta-Retinoic acid
Betarretin
BIDD:GT0483
BIDD:PXR0081
BML2-E05
bmse000562
BP-20401
BPBio1_000082
BR-73126
BRD-K06926592-001-01-7
BRD-K71879491-001-15-0
BRD-K71879491-001-22-6
BRN 2057223
BSPBio_000074
BSPBio_001500
C00777
CAS-302-79-4
CCG-39912
CCRIS 3294
CHEBI:15367
CHEMBL38
cid_444795
cis-Retinoic acid
Cordes vas
Cordes VAS [Germany]
CPD000058245
CS-1269
D00094
DB00755
Dermairol
DSSTox_CID_1239
DSSTox_GSID_21239
DSSTox_RID_76031
DTXSID7021239
Effederm
Effederm [France]
EINECS 206-129-0
Epi-aberel
EU-0101061
Eudyna
GS-3578
GTPL2644
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS2095D16
HMS2236N03
HMS3259E11
HMS3263E04
HMS3402K22
HMS3411B09
HMS3675B09
HMS3712D16
HMS502N05
HSDB 2169
HY-14649
IDI1_000903
IDI1_033970
Isotretinoin;(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
J10054
L000833
LMPR01090019
Lopac0_001061
LP01061
LS-1154
MFCD00001551
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MLS002548861
MLS006010222
NC00481
NCGC00017280-05
NCGC00017280-06
NCGC00017280-07
NCGC00017280-08
NCGC00017280-09
NCGC00017280-10
NCGC00017280-12
NCGC00017280-15
NCGC00017280-16
NCGC00017280-17
NCGC00017280-18
NCGC00017280-19
NCGC00017280-20
NCGC00017280-23
NCGC00021808-04
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-11
NCGC00021808-14
NCGC00021808-15
NCGC00254179-01
NCGC00259879-01
NCGC00261746-01
Nexret
NSC 122758
NSC-122758
NSC-759631
NSC122758
NSC759631
Opera_ID_1055
PDT-002-002
Pharmakon1600-01502016
Prestwick_424
Prestwick2_000257
Prestwick3_000257
PubChem16466
Q-200610
Q29417
QCR-120
R 2625
R0064
REA
Refissa
Renova
Renova (0.02% cream)
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retinoic acid
Retinoic acid all trans
Retinoic acid, >=98% (HPLC), powder
RETINOIC ACID, ALL TRANS
Retinoic acid, all-trans-
Retinoic acid, all-trans- (8CI)
Retinoic acid, cis-
Retinova
Retionic acid
Retisol-A
Ro 1-5488
S-1635
s1653
SAM002264647
SBB065722
SBI-0051031.P003
SC-16932
SCHEMBL19091395
SCHEMBL3145
SHGAZHPCJJPHSC-YCNIQYBTSA-N
SMR000058245
SPECTRUM1502016
Spectrum5_001746
Spectrum5_001933
SR-01000000239
SR-01000000239-12
SR-01000000239-13
SR-01000000239-14
SR-01000000239-15
SR-01000000239-3
SR-01000000239-4
SR-01000000239-6
SR-01000000239-7
ST057075
ST2407905
Stieva-A
SW203749-4
TNP00194
Tox21_110812
Tox21_110812_1
Tox21_202330
Tox21_300305
Tox21_501061
trans-Retinoate
trans-Retinoic acid
trans-Retinoic acid|||Retinoid analogues
Tretin M
tretinoin
Tretinoin - Retinoic Acid
Tretinoin (JAN/USP/INN)
Tretinoin (Retinoic acid)
Tretinoin (TN)
Tretinoin [USAN:INN:BAN]
Tretinoin [USAN:USP:INN:BAN]
Tretinoin 0.1% cream or placebo
tretinoin liposome
Tretinoin, all-trans-
Tretinoin, European Pharmacopoeia (EP) Reference Standard
Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material
Tretinoin, United States Pharmacopeia (USP) Reference Standard
Tretinoin(Aberela)
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (French)
tretinoine (French) (EINECS)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
TRETINON
UNII-5688UTC01R
UPCMLD-DP097
US10188615, at-RA
Vesanoid
Vesanoid (TN) (Roche)
Vesnaroid
Vitamin A acid
Vitamin A acid, all-trans-
Vitamin a acid, trans-
Vitamin A1 acid, all-trans-
Vitamin-A-sA currencyure
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
ZINC12358651

US Patents and Regulatory Information for SOLAGE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almirall SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Johnson and Johnson
Moodys
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.